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These results indicate that ESAQ-plates are the most practical 
and simple method to test susceptibllity and antibiotic synergy of 
enterococci in a routine clinical microbiology laboratory. 
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[el Comparative Study of Amplicor PCR and Ligase 
Chain Reaction for Direct Detection of M. 
tubemlosis in Clinical Specimens 
C.M. Gilpin, M.A. Abdelaal, A.O. Osoba. Department cfPatholoD, 
King Khalid National Guard Hospital, Jeddah, Saudi Arabia 
Objectives: To compare the sensitivity and specificity of two 
DNA amphfication techniques, Amplicor Polymerase Chain reac- 
tion (PCR) and Ligase Chain Reaction (LCR) in the detection of 
M. tuberculosis (MTB) in clinical specimens. 
Methods: 326 patient samples were selected for this study on the 
basis of positive acid fast bacilli (AFB) microscopy by Ziehl Neelsen 
(ZN) stain, prior history of tuberculosis on antituberculosis therapy, 
clinical suspicion of tuberculosis with negative miaoscopy or on 
culture positive samples. Each sample in addition to microscopy and 
culture for Mycobacteria was tested by both Amplicor PCR and 
LCR. 
Results: Of the 326 patient samples, 74 specimens were culture 
positive for MTB and 46/74 (62%) were AFB smear positive. All the 
46 smear positive-MTB positive cultures were LCR positive (100%) 
and 44 (95.6%) were positive by Amplicor PCR. In the 28 smear 
negahve-MTB positive cultures 25 (89.2%) were LCR positive and 
21 (75.0%) were Amplicor PCR positive. Of the 326 patient sam- 
ples 68 (20.9%) specimens were culture positive for non-tuberculous 
Mycobacteria (NTM) and in all both Amplicor PCR and LCR gave 
negative results. 
Conclusion: In smear positive specimens the high specificity of 
both methods allows for the detection and diflerentiation of MTB 
horn NTM in a single specimen. In this study LCR showed greater 
sensitivity than Amplicor particularly in smear negative specimens. 
I P666 I Evaluation of the Abbott LCx Mywbacterium 
tuberculosis Assay for Direct Detection of 
Mywbacterium tuberculosis in Respiratory 
Specimens 
E Gamboa, J.M. Manterola, E. Gazapo', J. Lonca, J. Ruiz', 
L. Matas, E. Padilla, C. Rodrigo', V. Ausina. 'Abbott, Madrid, 
Servicio de Minobiologia, Barcelona, Spain, 'Neumologia y Hospital 
Universitario Germans Trim i Pujol, Barcelona, Spain, 'Pediafrfa, 
Hospital Uniwsitario Germans Trim i Pujol, Barcelona, Spain 
Objetives: Evaluate the performance of Abbott LCx Mycobacfm'um 
tuberculosis (MTB) Assay (Abbott Laboratories, Diagnostic Division. 
Illinois, USA) and compare thls method of DNA amplification with 
standard culture and staining techniques. 
Methods: we have investigated 520 respiratory specimens col- 
lected h m  326 patients. The samples were digested and decontam- 
inated with sodium dodecyl sulfate (SDS)-NaOH. The pellet was 
resuspended with 30 ml of sterile water and centrifuged at 3300 
g for 20 minutes, and the supernatant was removed. The sedunent 
from all specimens was finally suspended in 2.2 ml of 0.067 M phos- 
phate b d e r  @H 6.8). For all specimens, half of sediment was kept 
a -80°C for the target-amplified test, and the other half were in- 
oculated onto Lowenstein-Jensen and Coletsos, and into BACTEC 
12B me&um (Becton Dickinson, Maryland, USA), and used for 
acid-fast staining. The identification of mycobacteria was reahzed 
for routine biochemical methods, gas-liquid chromatography and 
the Accuprobe DNA probes (Gen-Probe, San Diego, C a .  The 
Abbott LCx MTB Assay was performed with 500 p1 of pretreated 
(SDS-NaOH) specimen according to the manufacturer's package in- 
sert. 
Results: Overall sensitivity, specificity, positive predictive value 
and negative predictive value were 90.8, 100, 100, and 94.7%. re- 
spectively, for Abbott LCx MTB Assay; and 88.2, 100, 100, and 
93.4%, respectively, for culture. 
Conclusions: The Abbott LCx MTB Assay is a admissibly sensi- 
tive and specific technique for the rapid detection of M .  tuberculosis 
in respiratory specimens. 
lP6671 Comparison of the Cobas Amplicor MTB System 
with Amplicor MTB Test and Culture for 
Detection of Mycobactenurn tuberculosis in 
Respiratory Specimens 
E Gamboa, J.M. Manterola, J. Lonca, J. Ruiz', L. Matas, 
PJ. Cardona, C. Rodrigo *, V. Ausina. Senricio de Minobiologia, 
Hospital Universitario Germans Trias i Pujol, Barcelona, Spain, ' Sewicio 
de Neumologia, Hospital Univmitario Gemrans Trias i Pujol, Barcelom, 
Spain, 'Servin'o de Pediafria, Hospital Unimitario Germans Trias i 
Pujol, Barcelona, Spain 
Objectives: Evaluate two commercially available amplification sys- 
tems, the Roche Cobas Amplicor Mycobacterium tuberculosis (MTB) 
automated system and the Roche Amplicor Mycobactenurn tubercu- 
losis test (Amplicor MTB; Roche Diagnostic Systems, S o m e d e ,  
NJ.) and compare these methods with standard culture and staining 
techniques. 
Methods: We investigated 504 respiratory specimens collected 
fiom 343 patients. The samples were digested and decontaminated 
with sodium dodecyl sulfate (SDS)-NaOH. The sediment from all 
specimens was finally suspended in 2.2 ml of 0.067 M phosphate 
buffer @H 6.8). For all specimens, half of sediment was kept a 
-80°C for preparation of DNA, and the other half were inocu- 
lated onto Zwenstein-Jensen and Coletsos, and into BACTEC 12B 
medium (Becton Dickinson, Maryland, USA), and used for acid-fast 
staining. The identification of mycobacteria was realized for rou- 
tine biochemical methods, gas-liquid chromatography and the Ac- 
cuprobe DNA probes (Gen-Probe, San Diego, C a .  The Cobas 
Amplicor (CA) MTB system and Amplicor MTB test were done 
accordmg to the manufacturer's instructions. 
Results The sensitivities of the CA MTB and Amplicor MTB 
systems were 94 and 91, respectively. For both systems the specificity 
obtained was 100%. 
Conclusions: The CA system brings true PCR automation to 
clinical mycobacteriology laboratories. In addition the accuracy of 
automated results, the CA system had a highest sensitivity that Am- 
plicor MTB test for detection of Mycobactmiurn tuberculosis in respira- 
tory specimens. 
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I P668 I Evaluation of the LCx'" MTB Amplification Assay 
for the Rapid Detection of Mycobactenurn 
tubercdosis Complex in Respiratory Specimens 
€! Rohner, B. Ninet, 0. Delaspre, R. Auckenthaler. Bacferiology 
hboratory, University Hospital Geneva, Switzerland 
The LCx" MTB amplification assay (Abbott Diagnostics, Chicago, 
USA) applies the ligase chain reaction to detect Mycobaam'um tubercu- 
losis complex directly in decontaminated respiratory specimens. The 
LCx'" MTB probe set detects the gene encoding for protein antigen 
B. We determined the performance of the assay on 368 respiratory 
specimens. 
The results were compared to cultures on BACTEC 12B (Becton 
Dickinson, Sparks, USA) liquid media, Coletsos (BioMkrieux, Lyon, 
France) and Stonebrink (Becton Dickmson, Sparks, USA) solid me- 
dia as well as to the microscopy results of auramine colored samples. 
Of the 368 samples, 87 (24%) were culture positive for M. tuberculo- 
sis, of which 60 (69%) were smear positive. For the LCx'" MTB test, 
the overall sensitivity and spec&ity as compared to culture for M. 
tuberculosis was 90% (78/87) and 96% (270/281) respectively How- 
ever, for the 297 smear negative specimens, the sensitivity decreased 
to 74% (20/27). 
The LCx" MTB assay proved to be a well automated and a reliable 
rapid test to detect M .  tubenulosis in respiratory specimens. 
I P669 1 LCx MTB Evaluation in Greek Population 
E. Marinis I ,  E. Fakiri ' , NJ. Le&s ', G. Schroder3, 
D. Papanikolaou '. 'Nafional Mycobateria Reference Centre, Sofiria 
Hospital, Athens, Greece, 'Microbiology Dep. of Mediral School, Athens 
University, Greece, 'Abbott Diagnosticc Division, Germany 
Objectives: The purpose of the study was to evaluate the new 
Abbott LCx MTB assay for the detection of Mycobactenurn tuberculosis 
(MTB) in clinical specimens. 
Methods: A total of 271 respiratory specimens were included in 
the study. Decontamination was done by the NaOH method. The 
performance characteristics of the LCx MTB assay were compared to 
solid culture (Loewenstein-Jensen) and microscopy (Ziehl-Neelsen 
stain of b e d  smears) results. All positive culture results were spe- 
ciated by hybriduation assay using the Gen Probe method (Ac- 
cuprobe). Discordant results between LCx and culture were resolved 
mainly by patient history, but also by other methods, such as liq- 
uid culture (Bactec) and probe amplification (Gen Probe). The LCx 
MTB assay, based on the Ligase Chain Reaction (LCR) amphfica- 
tion technology, was performed accordmg to the instructions of the 
manufacturer. Results were available within one day (5 hours). 
Results: For the LCx MTB assay, the overall resolved sensitivity 
was 96.3% (129/134) and the overall resolved specificity was 100% 
(137/137). Culture resolved sensitivity and specificity were 94.8% 
(127/134) and 100% (137/137), respectively 
Conclusions: The LCx MTB assay has a performance compara- 
ble to culture. It provides the medical community with a new rapid 
and sensitive diagnostic test that may lead to early treatment and 
isolation of infectious patients. The LCx MTB assay is user-Gendly 
with enough stopping points and modular instrumentation that can 
be easily used by our laboratory. 
I P670 I Detection of Mycobactenurn tuberculosis in 
Respiratory Specimens Using the New Abbott 
LCx MTB Assay 
S. Sheehan I ,  G. Scbroder *, J. Garland '. 'Microbiology Laboratory, 
Univenity Hospital, Cork, Ireland, 'Abbott Diagnosfirs Diuision, 
Germany and Ireland 
Objectives: The purpose of the study was to compare the new 
Abbott LCx MTB assay, using Ligase Chain Reaction (LCR) tech- 
nology for the detection of Mycobactenurn tuberculo+ (MTB), to our 
routine methods, microscopy/smear and culture. 
Methods: A total of 341 respiratory specimens from patients sus- 
picious of being infected with MTB were induded in the study. 
Decontamination of all clinical samples was done according to the 
NaOH method. Microscopy was done by Auramine stain for screen- 
ing and Ziehl-Neelsen stain for confirmation purposes. Loewen- 
stein-Jensen culture was performed, and samples were inoculated for 
a maximum of 8 weeks to report a negative result. The LCx MTB 
assay was run accordmg to the instructions of the manufacturer, total 
assay time was 5 hours. 
Results Afier resolution of all discrepant samples between cul- 
ture and LCx according to h c a l  history information, the following 
results were obtained: In smear positive samples, the resolved sensi- 
tivity of the LCx MTB assay was 98.3% (117/119) compared to 
88.2% (1051119) for culture. In smear negative samples, the resolved 
sensitivity of LCx was 92.3% (48152) compared to 50.0% (26/52) 
for culture. The resolved specificities were 100% (170/170) for both 
assays. Resolved sensitivities for all samples were as follows: 96.5% 
(165/171) for LCx and 76.6% (131/171) for culture. 
Conclusions: Our results demonstrate that the new LCx MTB 
assay has very good sensitivity compared to culture, even in smear 
negative samples. It can be recommended for routine testing of all 
respiratory samples suspicious of containing MTB. The LCx MTB 
assay is fast, results are available within only one day, compared to 
3-8 weeks needed for culture results. 
Ip6711 Direct Detection of Mycobactenurn tuberculosis 
Complex by Gen-Probe Amplified M. 
tuberculosis Direct Test and Roche Amplicor M. 
tuberculosis Test 
A. Carricajo, G. Zambardi, G. Aubert. Department ofBacteriology, 
CHU Belleoue Hospital, Saint-Etienne, France 
Objectives: Prospective study of testing of cl~nical samples for M. 
tuberculosis (Mt) complex organisms using two gene ampMication 
methods 
Methods: 86 clinical specimens (27 respiratory and 59 extrapul- 
monary specimens) from 69 patienn were tested for the presence of 
Mt complex by rRNA amplification (Gen-Probe Amphfied Mt Di- 
rect Test [AMTD]) and PCR (Roche Amplicor Mt Test [Amplicor 
PCR]). All respiratory and urine samples were decontaminated with 
sodium dodecyl (lauryl) sulfate (SDS)-NaOH prior to testing. The 
results were compared with those obtained by conventional Lowen- 
stein-Jensen tube culture as well as with clinical data. 
Results: Of the 86 specimens, 12 were positive for Mt by cul- 
ture. Of these 12 samples, 8 were positive by Amplicor PCR, 8 by 
both Amplicor PCR and AMTD, and 9 by AMTD. The 6 samples 
smear-positive were also positive by the two amphfication methods. 
Positive results with the Amplicor PCR test were obtained with 3 
culture-positive samples only after dilution to 1/5 of the samples 
after DNA extraction. Specificity was 94.6% (69/74) for AMTD 
and for Amplicor PCR. Of the 9 discordant samples (culture neg- 
ative/amplification positive) 1 was positive by Amplicor PCR and 
AMTD, 4 were positive by Amplicor PCR only and 4 were positive 
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by AMTD only Of these 9 discordant samples, only 5 were from 
patients receiving antituberculous treatment. 
Conclusions: These two amplification methods allow rapid de- 
tection of Mt in h c a l  samples with a comparable sensitivity and 
spedcity. However, the Amplicor PCR method requires testing for 
inhibitors. Under our conditions, positive results in both tests had a 
very high positive predictive value. 
p] One-Tube Nested PCR for Detection of M. 
tuberculosis Complex 
A. Chprasert ' , N. Gengvinij ' , S. PatranaCitsagul '. 'Department of 
Microbioloa, Siriraj Hospital, Mahidol University, Bangkok, Thailand, 
zOfFe ofhearch and Development, Siriraj Hospital, Mahidol 
University, Bangkok, nailand 
Objectives: To achieve the most appropriate and specific method 
on PCR-based for detection of M. tuberculosis. 
Methods: A total of 25 mycobacterial species, 12 bacterial and 
6 yeast species were used. DNA from 67 st ra ins  of mycobacteria, 
5 gram positive bacteria and 6 yeasts were isolated by using mod- 
ified physical rupture technique. For gram negative bacteria, cells 
were lysed with lysozyme, proteinase K and SDS. All DNA samples 
were preapitated with ethanol, resuspended in Tris-EDTA, quanti- 
fied and stored at -2O'C until used. PCR was pelformed by using 
one-tube nested method and 16s rFWA gene as the target. The 
primers were 16SOL-16SOR and 16SIL-16SIR. PCR was done 
in a total volume of 50 p1 in normal essentul composition with 2 
pmole 16SOL-16SOR and 25 pmole 16SIL-16SIR. The reaction 
mixture was subjected to 20 cycles of 94'C 1 min, 70°C 30 sec, 
72°C 1 min followed by 35 cycles of 94OC 1 min, 50°C 30 sec, 
72°C 1 min. Amplified products (5 pl) were detected by agarose gel 
electrophoresis. 
Results The specific amplified product with the size of 306 bp 
were obtained from all 24 tested strains of M. tuberculosis, M .  bovis and 
M .  bovis BCG. The lower limit of detection of M .  tubemlosis DNA 
was 100 fg. There were no specific amplified product detected h m  
other tested microorganisms except some strains of M .  marinum, M. 
ulerans and M .  chelonae. 
Conclusions: By using one-tube nested PCR, the DNA of M. 
tuberculosis complex could be detected as least as 100 fg in one and a 
half day. This should be practical for applying in direct detection of 
M .  tuberculosis in clinical samples. 
lp6731 When is it Useful to Order a M.tbePCR Test for 
Ziehl-Neelsen Positive Clinical Specimens? 
K. Jaton ', J.E? Zellweger', V. Beer', J. Bille '. 'Institute of 
MicrobioloSr, CHUY Switzerland, 'University Medical Policlinic, 
Laucanne, Switzerland 
Direct genomic amplhcation of M .  tuberculosis complex (M.  tbc) in 
clinical samples has dramatically speeded the laboratory dagnosis of 
tuberculosis. But the clinical indications for doing this test have not 
been clearly defined, particularly for Ziehl-Neelsen positive (ZN+) 
specimens. In this situation it is of importance to rapidly Meren- 
tiate M. tbc from MOTT. For this reason we analysed the culture 
results obtained during three years (1994-96) on all Z N t  samples, 
according to the type of specimens (respiratory [R] versus non res- 
piratory m ] )  and to the patient's characteristics (immunocompro- 
mised [ICH], versus immunocompetent hosts). 
In immunocompetent hosts, ZN+ R specimens grew M .  tbc in 
96% of the cases as opposed to 21% in ICH. The corresponding 
yield for the ZN+ NR specimens was 85% for immunocompetent 
hosts and 50% for ICH. Therefore, M .  tbc-PCR appears of little use 
C u l m  results of ZN+ specimens (N = 127) 
Respiratory spcdmcns n = 87 Non rnpintoryspccimcns n = 40 
no F ICH' no yes 
M. tk 70 3 
MOTT 3 11' 
17 10 
33 10 
'HIV, cancer, chemoth., comcosreroidsZ 8/11 < 40 y. ' 213 .c 5 y. 
in immunocompetent hosts (except in children) whereas it may be 
very useful in ICH, in order to Meredate  M. tb h m  MOTT 
infection in ZN+ R and NR specimens. 
lp674] Molecular Diagnosis of Tuberculous Meningitis 
in a Low Endemic Area and Clinical Significance 
of the Results 
K. Jaton ', G. PfyEer ', E? Rudaz ', l? Kissling ', R. Weber ', 
J. Bille '. 'Instifut de Minobiologie, CHUY Lauranne, Switzerland, 
'Swiss Nat. Centerfor Mywbacteria, Univ. of Zurich, Switzerland, 'Div. 
oflnfect. Diseases, Univ. Hosp., Zurich, Switzerland 
The diagnosis of tuberculous (Tb) meningi& has ahays been a- 
cult. Thus, molecular diagnosis is very appeakng. Four methods were 
blindly compared to Ziehl-Neelsen (ZN), culture results and clini- 
cal outcome: MTD@ Test (Gen-Probe), Amplicor@ PCR moche; 
I), home-made PCR (11) targeting IS6110 and tuberculostearic acid 
analysis (TBSA). 
55 cerebrospinal fluids (CSF) samples fium 53 patients @ts) have 
been analyzed so far for tuberculosis (TB). 42 samples were negative 
for all methods (76%). ZN was positive for 0/55 CSF, TBSA for 
1/55, and culture for 2 CSF from one pt. 3 were positive with all 
amplification methods and corresponded clinically to TB meningitis. 
The other 10 CSF showed discrepant results: 
MTD PCRI PCRII n Chniolutuation 
~ 
2 
2 
1 
1 
2 
1 
1 
~~~~ ~ ~~ 
Activc TB 
Patients under TB maenent (2.5 and 6 months) 
History of TB; ructivltion? 
Inconclusive 
No evidence of TB; Wsc positives 
Inconclusive 
No evidence of TB; & posicivc 
Results of amplification tests for M .  tuberculosis in CSF samples of 
pts with suspected meningitis should be interpreted with extreme 
caution and in light of an active or a previous Tb as well as therapy. 
lp6751 Inhibition Rate of Two PCR Methods for the 
Detection of M. tuberculosis Complex (Mtbc) 
from Respiratory and Non Respiratory Samples 
I. Antonioli ', K. Jaton ', G. Praz ', J. Bille '. ' ICHY Sion, 
Switzerland, 'Centre Hospitalier Unimitaire &'nudois, Lausam, 
Switzerland 
The high sensitivity of PCR could be particularly useful in c h i -  
cal samples (spls) with few bacilli, such as in extrapulmonary TB. 
However, the sensitivity of PCR can dramatically fall, due to the 
presence of inhibitory substances. In t h i s  study, we blindly compared 
the inhibition rate of two merent PCR methodologies, a commer- 
cial PCR (Amplicop, Roche) and a home-made PCR (IS6110) for 
the detection of Mtbc in respiratory and non respiratory spls. The 
inhibition was controlled by s p h g  the spls. with Mtb DNA. So 
far, 71 respiratory spls., 39 various body fluids (13 urines, 1 CSF, 8 
abscesses, 3 ascites, 6 pleural fluids and 8 others) and 25 tissue spls. 
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(9 lymph nodes and 16 other biopsies) were analysed. We compared 
the % of inhibition for each group of spls. The results are: 
Samples N=135 Mcthods Inhibinon N = (‘A) 
Rapintoty N=71 AmplicoP 5 0 
Body fluids N = 39 AmplicoP 4 (10) 
Tissue sampler N = 25 Amplico? 7 (28) 
Home made-PCR 4 (6) 
Home made-PCR 0 (0) 
Home made-PCR 1 (4) 
The simple lysis method ofAmplicoF to release DNA, in contrast 
to the silica extraction procedure (Boom R. et al. JCM 1990) used 
in the home-made PCR, could be one of the reasons explaining the 
different inhibition rates observed. 
In conclusion, the systematic use of controls of inhibition is highly 
recommended for both methods. Morever, the hgh  inhibitory ef- 
fects of Amplicop in body fluids and tissue spls. make this PCR 
method less appropriate for the dugnosis of extrapulmonary tuber- 
culosis, particularly in tissue spls. 
FI Clinical Trials Results Using the Second 
Generation Amplified Mycobacterium 
Tuberculosis Direct (MTD) Test 
V. Jonas, M. Acedo, M. Alden, K. D’Amour, G. Mathews. 
Gen-Probe Incorporated, San Diego, CA, USA 
Objectives: To determine the performance of the second genera- 
tion MTD test. 
Methods: A simplified version of the MTD test, with fewer steps 
and a shorter amphfication time was used to test respiratory sedi- 
ments at 5 clinical trial sites, including 4 in the U.S. and one in 
Switzerland. Patients suspected of having tuberculosis were enrolled 
in the study. From 1-6 samples per patient were tested. The sam- 
ple was increased fbm 50 pL to 450 pL to reduce the amount of 
sampling variability and increase the chance of getting M. tuberculosis 
into the test. 
Results: The data available to date have been generated with 
AFB smear positive specimens. A total of 125 specimens f b m  54 
untreated patients were tested with the MTDl and MTD2 tests. 
The sensitivity and specificity of MTDl were 97.8% (88190) and 
91.4% (32/35), respectively. The sensitivity and specificity of the 
MTD2 test were 97.8% (88/90) and 97.1% (34/35), respectively. 
The single false positive result for MTD2 came from a patient with 
diagnosed, active tuberculosis. Data are currently being evaluated for 
specimens irrespective of the AFB smear result. 
Conclusions: The use of this test in the clinical laboratory should 
further enhance the rapidity with which the diagnosis of tuberculosis 
can me made. 
P677 I Direct Detection of Mycobacterium tuberculosis 
(Mtb) from Smear Negative, Culture Positive 
Sputa with Thermophilic Strand Displacement 
Amplification (tSDA) 
T. Fort, M. Collis, J. Hahn, 0. Llorin, J. Price, C. Rostkowski, 
K. Williams, H. Yang, D. Yursis. Becton Dirkinson Microbiology 
Systems, 54 Loveton Circle, Sparks, ML) 21152, USA 
Objectives: Evaluate a tSDA assay for the direct detection of Mtb 
f b m  smear negative, culture positive sputa. 
Methods: Thermophilic strand displacement amplification 
(tSDA) is an in uitro, isothermal nucleic acid amplification technique 
based on the nicking of a hemi-modified restriction site and dis- 
placement of the downstream DNA strand. We have applied tSDA 
to the duect detection of Mtb from respiratory specimens. 105 Mtb 
smear negative, culture positive and 105 Mtb smear negative, culture 
negative samples were evaluated. The 105 smear negative, culture 
positive samples were comprised of 80 stored NALC pellet remain- 
ders, which were processed to the NALC stage at various external 
clin~cal sites, and 25 sputa samples which were processed to the 
NALC stage at Becton Dickinson. All samples received additional 
processing in-house to remove inhibitors, concentrate bacteria and 
release target DNA. Flfty-five pl of the processed samples were trans- 
ferred to disposable decontamination-amplification devices (DADS), 
which contain enzymes, primers, M P s  and other components 
needed for decontamination and amphfication. Following amplifi- 
cation, products were transferred to a microtiter assay device (AD) 
where amplified products were detected by chemiluminescence. De- 
contamination, ampkfication and detection were conducted on an 
automated temperature controller. 
Results: P r e b a r y  unresolved performance includes 92% sen- 
sitivity for kshly processed NALC pellets, 78% sensitivity for stored 
NALC remainders, 94% specificity and 0% inhibition. Following 
resolution of four reported negative NALC remainders, specificity 
increased to 98%. 
Conclusions: Coupling tSDA with the described sample pro- 
cessing method allows highly sensitive direct detection of Mtb h m  
smear negative, culture positive sputa. 
I P678 I A Novel Assay for the Simultaneous Detection 
M.T. Jucker, A. Doran, G.F? Galarpe, E.G. Lasalita, R. Lankford, 
S.C. Lee, V Jonas. Gen-Probe Incorporated, San Diego, CA, USA 
Objectives: To develop a novel target capture based assay to si- 
multaneously detect and Werentiate Mycobactm’um tuberculosis com- 
plex (MTB) from other mycobacteria (MOTT; M. avium complex 
(MAC), M. kansasii (MKA), M. snofulaceum, M. gastri, M. simiae) 
dmctly h m  chical specimens 
Methods: The assay features (a) a one-tube format throughout, 
@) detection of any of the hted mycobacterial species with an an- 
alytical sensitivity level of less than one cell, (c) detection of one 
cell of MTB in a background of 104MOTT cells, and vice-versa, 
and (d) neghgible signal above background h m  non-mycobacterd 
rRNA. In thls assay, mycobacterid 16s rRNA is specifically cap- 
tured and inhibitory compounds are removed h m  specimens using 
paramagnetic particles. A region of the captured rRNA is ampli- 
tied by transcription mediated amplification (TMA). The resulting 
amplicons are detected by the hybribtion detection assay (HPA). 
Results: Initial results show that the assay detects 1 CFU of MTD 
or MOTT in pure system or 2000 copies in rRNA spiked sputum 
sediments. Ninety-eight sputum sedunents were tested (unspiked) 
using the new target capture based assay All 46 MTB culture positive 
samples were detected by the MTB probe and none by the MAC or 
MKA probe. 
Conclusions: This target capture based assay looks promising for 
the detection of mycobacteria in sputum sediments. 
of Clinically Relevant Mycobacteria 
w] An Automated Probe System for the Diagnosis 
of Mycobactenurn tuberculosis Infection 
G. Fadda ’, E Ardito B. Postern ’, M. Sanguinetti ’, C. Chezzi ’, 
L. Polonelli’, S .  Conti’, G. Fanti ’, C. Galli3. ’Institute .f 
Microbiology, Catholic University ofRoma, Italy, ’Institute $Microbiology, 
University .f Pama,  Italy, ’Abbott Dingnostics Divison, Roma, Italy 
Objectives: to evaluate the performance of a new automated DNA 
amplification method for the detection of M. tuberculosis (Abbott 
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LCx MTB) in comparison with conventional culture methods in 
two different Italian laboratory settings. 
Methods: we selected 472 samples from those routinely assayed 
during a three months period in order to include the highest possi- 
ble number of positives for M. tuberculosis (MTB). All samples have 
been previously tested for acid-fast bacilli (AFB) and then assayed by 
both conventional solid culture (Loewenstein-Jensen medium) and 
the radiometric Bactec liquid method. The 305 samples collected 
in Rome and 6 of the 167 of the samples tested in Parma were 
obtained fiom HIV-1 infected patients, whereas the remaining 161 
samples came fbm Merent hospital departments; 11 samples were 
non-respiratory. The clinical hstory of the patients was used to re- 
solve the discordant results between LCx and culture. 
Results: a total of 99 samples were culture positive for MTB (96 
by both LJ and Bactec, 3 by Bactec only); of those, 56 were positive 
for AFB (56.6%) and 95 by LCx (96%), that gave a positive result also 
on 71373 MTB negatives by culture. Since all 11 discordants were 
obtained from patients with a confirmed diagnosis of MTB mfec- 
tion (response to specific treatment or positive isolates on previous 
and/or subsequent samples), and LCx was negative on all samples 
with MOTT, the final values of sensitivity and specificity for the 
LCx assay were 96.2% and loo%, respectively, with a slightly higher 
sensitivity on HIV-infected patients. 
Conclusions: results by the automated DNA amplification 
method were equivalent to culture; LCx represents an useful tool 
for the rapid diagnosis of MTB. 
1 P680 1 Development of an Amplified VIDAS Test for the 
Detection of Mycobacterium tuberculosis (Mtb) 
from Sputum Sediments 
K. Ckrk', C. Knott', C. Light', M. Longiaru', T. Quigley', 
S. Santa Ana ' , B. Weinbaum I ,  L. Catanzariti ', G. McKinley ', 
J. Moe ', M. Vera-Garcia '. ' Gen-Probe Incorporated, San Diego, C4, 
USA, 'bioMerieux, Znc., Rockland, MA, USA 
Objectme: Develop a specific and rapid automated test that identi- 
fies Mtb from sputum sediments. 
Methods: Mtb rRNA was amphfied using Gen-Probe's isother- 
mal Transcription Mediated Amplification (TMA). The amplified 
product was detected on a W A S  immunoassay instrument using 
enzyme-linked fluorescent signal probes. The assay was run against 
a specificity panel of 14 non-Mtb mycobacteria, 6 Mtb complex 
species and 4 related genera. A panel of 98 &cal specimens were 
also tested. 
Results The assay offers specificity among the highly conserved 
species of mycobacteria, idenhfylng only organisms that are in the 
Mtb complex. Clinical specimens culture positive for M. gordome, M .  
fortuitum and M. auium were negative by the amplified VIDAS test. 
Of the total samples tested, 89 were negative and six were positive 
for Mtb by both culture and amplification. Three specimens, from 
patients undergoing treatment for pulmonary tuberculosis, were pos- 
itive by our amphfied test, but culture negative. Detection was possi- 
ble from these three samples due to the sensitivity of the assay whch 
detects down to 1 fg of Mtb rRNA or less than one Mtb cell per 
test. Bloody clinical specimens did not elevate backgrounds. Sedi- 
ments can contain up to 1% v/v of blood and s t i l l  be amplified. 
As many as lo8 Sfq~hylococncs aureus can be present per test without 
interfering in the assay. 
Conclusion: Prekminary results from the TMA-amplified Mtb 
assay on the Vidas Instrument, at the very least, will match culture 
for sensitivity and specificity, but can be completed in 2-3 hours 
instead of weeks. 
I P681 1 Evaluation of the Reformulated Gen-Probe 
Mycobacterium Kansasii AccuPmbe Test for the 
Identification of M. kansasiifrom Cutture 
C. Knott, M. Bott, S. Yamagata, D. Riggan, S. Brentano, 
I. Andruszkiewicz, T. Endozo, G. Mathews. Cen-Probe Zncorporated, 
San Bego, CA, USA 
Objective: Evaluation of the Mycobacterium Kansasii Culture 
Identification Test for the detection of M. kansasii and related sub- 
groups isolated &om culture. 
Methods: Recently, strains biochemically similar to M. kansasii 
have been observed that failed to hybridize with the Mycobac- 
terium Kansasii Culture Idendcation Test. A representative panel 
of these unreactive M. kansasii strains, characterized by conventional 
biochemical methods, HPLC analysis, and DNA probe methodolo- 
gies, was obtained for further evaluation. Sequence analysis of por- 
tions of the 16s and 23s ribosomal RNA genes revealed scattered 
point differences in nudeic acid sequence, confirming the existence 
of subgroups of M. kansasii. DNA probes complementary to the 
unique rRNA sequences of these variant strains were designed and 
incorporated into the existing kit probe reagent. 
Results The performance of the Mycobacterium Kansasii Cul- 
ture Idendcation Test was evaluated at five sites in Europe and the 
United States. A total of 535 clinical isolates from 51 species of 
Mycobacteria, including 353 target and 182 nontarget strains, were 
tested. The resulting sensitiwty and specificity of the reformulated 
Mycobacterium Kansasii Culture Identification Test were 98% and 
100% respectively. 
Conclusion: The Mycobacterium Kansasii Culture Identification 
Test provides a rapid, objective, and accurate method for the iden- 
hfication of M. kamasii and genetic variants of M. kansasii isolated 
fiom culture. 
I P682 I DNA Fingerprinting Analysis of Mpbactetium 
tuberculosis Complex by Ligation-Mediated PCR 
G. Prod'hom, C. Guilhot, A. Varnerot, G. Torrea, B. Gicquel, 
V Vincent. Institut Pasteur, Paris, France 
Objectives: To develop a rapid PCR method that is as discrimina- 
tive as FWLP reference method for typing M. tuberculosis complex 
Saains. 
Methods: Strain-speclhc electrophoretic patterns were obtained 
by amplification of one sided DNA sequences fbnlang the IS61 10. 
Compatible adaptators were linked to SalI-digested M. tuberculosis 
complex DNA. IS61 10 flanking sequences were then amplified us- 
ing 2 primers, one specific for the IS6110 and the other for the 
adaptator. 
Results: 19 M .  tuberculosis isolates h m  difXerent dusters or soli- 
tary cases gave different banding patterns, whereas isolates from the 
same cluster gave the same bandmg pattern. 14 s t t a i n s  of M .  bouis 
and M. tubmlosis with one or two IS61 10 gave a unique or two 
amphfied DNA fiagments respectively. For 5 cases we used nested 
PCR with primers specific for the direct repeat region (DR). We 
determined that the IS were inside the DR region and the amplified 
DNA fiagments correspond to IS flanking regions. 
Conclusions: The proposed method represents a useful tool for 
investigation of epidemiologically-related strains, of specla interest 
for determination of laboratory cross-contamination. Similarly to 
RFLP, the method has limited value for strains with low IS61 10 
copy number. 
